Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Sacramento, CA
NPI: 1558542209Primary Practice Location
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL CENTER
4301 X St, Sacramento, CA
Primary Employer
Regents of the University of CA
health.ucdavis.edu
HQ Phone
Get M.D., PHD Brian's Phone Numberphone_androidMobile
Get M.D., PHD Brian's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2008 - 2025
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
UC Davis School of Medicine
health.ucdavis.edu
Medical School
Until 2007
Stanford Health Care-Sponsored Stanford University
Fellowship • Medical Oncology
2009 - 2013
Residency • Internal Medicine
2007 - 2009
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 133 | 257 |
| 2 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 68 | 96 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 66 | 66 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 58 | 372 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 39 | 187 |
SMRT and N-CoR Corepressors Are Regulated by Distinct Kinase Signaling Pathways
Authors: Brian A. Jonas, Martin L. Privalsky
Publication Date: 2004-12
Proteinuria, Hypoalbuminemia, and Chronic Lymphocytic Leukemia: An Unusual Trio.
Authors: William Wung, Shubha Ananthakrishnan
Journal: J Investig Med High Impact Case Rep
Publication Date: 2018-03-14
Lead Sponsor: Brian Jonas
Collaborators: AbbVie, National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Venetoclax, DRUG: Azacitidine, DRUG: Decitabine
Lead Sponsor: Brian Jonas
Collaborators: National Cancer Institute (NCI), GlycoMimetics Incorporated
Intervention / Treatment: DRUG: Venetoclax, DRUG: Azacitidine, DRUG: Uproleselan
Lead Sponsor: Massachusetts General Hospital
Collaborators: AbbVie
Intervention / Treatment: DRUG: Venetoclax, DRUG: Azacitidine, DRUG: Cytarabine, DRUG: Idarubicin, DRUG: Daunorubicin, DRUG: Liposomal daunorubicin and cytarabine